Results
|
|
101.
|
|
|
|
102.
|
|
|
|
103.
|
|
|
|
104.
|
|
|
|
105.
|
|
|
|
106.
|
|
|
|
107.
|
|
|
|
108.
|
|
|
|
109.
|
|
|
|
110.
|
|
|
|
111.
|
|
|
|
112.
|
|
|
|
113.
|
|
|
|
114.
|
|
|
|
115.
|
|
|
|
116.
|
|
|
|
117.
|
|
|
|
118.
|
|
|
|
119.
|
|
|
|
120.
|
The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients. [electronic resource] by
- Petrera, Marilena
- Paleari, Laura
- Clavarezza, Matteo
- Puntoni, Matteo
- Caviglia, Silvia
- Briata, Irene Maria
- Oppezzi, Massimo
- Mislej, Eva Mihajlovic
- Stabuc, Borut
- Gnant, Michael
- Bachleitner-Hofmann, Thomas
- Roth, Wilfried
- Scherer, Dominique
- Haefeli, Walter-E
- Ulrich, Cornelia M
- DeCensi, Andrea
Producer: 20190325
In:
BMC cancer vol. 18
Availability: No items available.
|